Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Fortrea Holdings
FTRE
$1.71B
| $11.8M | ﹤0.01% |
590,428
+29,285
| +5% | +$688K |
|
1952
Viridian Therapeutics
VRDN
$2.3B
| $11.7M | ﹤0.01% |
516,213
+32,292
| +7% | +$528K |
|
1953
Cannae Holdings
CNNE
$660M
| $11.7M | ﹤0.01% |
615,152
-74,138
| -11% | -$1.43M |
|
1954
Amneal Pharmaceuticals
AMRX
$5.9B
| $11.7M | ﹤0.01% |
1,404,883
+202,863
| +17% | +$1.59M |
|
1955
Ecovyst
ECVT
$1.33B
| $11.7M | ﹤0.01% |
1,704,331
+230,351
| +16% | +$1.76M |
|
|
EVRI
1956
DELISTED
Everi Holdings
EVRI
| $11.6M | ﹤0.01% |
882,351
-218,061
| -20% | -$2.57M |
|
|
AHRT
1957
AH Realty Trust
AHRT
$539M
| $11.6M | ﹤0.01% |
1,067,261
-113,052
| -10% | -$1.32M |
|
|
SHOE
1958
Shoe Station Group
SHOE
$422M
| $11.5M | ﹤0.01% |
262,910
-45,152
| -15% | -$1.84M |
|
1959
Monro
MNRO
$410M
| $11.5M | ﹤0.01% |
399,132
-52,291
| -12% | -$1.35M |
|
1960
Nurix Therapeutics
NRIX
$2.56B
| $11.5M | ﹤0.01% |
511,720
-111,684
| -18% | -$2.53M |
|
1961
Adeia
ADEA
$3.44B
| $11.5M | ﹤0.01% |
965,423
+33,845
| +4% | +$393K |
|
1962
AdvanSix
ASIX
$546M
| $11.5M | ﹤0.01% |
378,156
-59,409
| -14% | -$1.62M |
|
1963
Enovix
ENVX
$960M
| $11.5M | ﹤0.01% |
1,404,631
+83,794
| +6% | +$870K |
|
|
VRN
1964
DELISTED
Veren
VRN
| $11.5M | ﹤0.01% |
1,860,312
+50,997
| +3% | +$364K |
|
1965
Unitil
UTL
$964M
| $11.5M | ﹤0.01% |
189,331
-17,348
| -8% | -$1.01M |
|
|
INFN
1966
DELISTED
Infinera Corporation Common Stock
INFN
| $11.5M | ﹤0.01% |
1,698,808
+39,917
| +2% | +$246K |
|
1967
Appian
APPN
$2.09B
| $11.4M | ﹤0.01% |
334,847
+3,817
| +1% | +$124K |
|
1968
Skyward Specialty Insurance
SKWD
$2.5B
| $11.4M | ﹤0.01% |
279,942
-18,872
| -6% | -$731K |
|
1969
Fluence Energy
FLNC
$2.08B
| $11.4M | ﹤0.01% |
501,940
+25,143
| +5% | +$455K |
|
|
THR
1970
DELISTED
Thermon Group Holdings
THR
| $11.4M | ﹤0.01% |
381,428
+19,083
| +5% | +$576K |
|
1971
Select Water Solutions
WTTR
$2.3B
| $11.4M | ﹤0.01% |
1,021,413
-58,438
| -5% | -$643K |
|
1972
Shutterstock
SSTK
$221M
| $11.4M | ﹤0.01% |
320,895
+13,539
| +4% | +$499K |
|
1973
Harrow
HROW
$1.48B
| $11.3M | ﹤0.01% |
251,629
+166,602
| +196% | +$5.63M |
|
|
PTVE
1974
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $11.3M | ﹤0.01% |
982,661
+16,029
| +2% | +$184K |
|
1975
Atlas Energy Solutions
AESI
$1.37B
| $11.3M | ﹤0.01% |
518,569
+25,999
| +5% | +$537K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.